| Dr Tuyet Pham, MD | |
|
1402 W Avenue H, Temple, TX 76504-5342 | |
| (254) 771-8411 | |
| Not Available |
| Full Name | Dr Tuyet Pham |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 1402 W Avenue H, Temple, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508396011 | NPI | - | NPPES |
| 120482146 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1204821469 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor University Medical Center | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who received sorafenib or sunitinib after surgery (5.6 years) and those treated with placebo (5.7 years).
On Oct. 8, MicroMed Cardiovascular (www.micromedcv.com), manufacturer of the HeartAssist 5™ left ventricular assist device (LVAD), was selected as one of the Top 50 Emerging Companies in the nation's largest venture capital competition, the Sixth Annual Pitching Across America competition.
The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival.
A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical guidelines for the use of aspirin in preventative care.
› Verified 5 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who received sorafenib or sunitinib after surgery (5.6 years) and those treated with placebo (5.7 years).
On Oct. 8, MicroMed Cardiovascular (www.micromedcv.com), manufacturer of the HeartAssist 5™ left ventricular assist device (LVAD), was selected as one of the Top 50 Emerging Companies in the nation's largest venture capital competition, the Sixth Annual Pitching Across America competition.
The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival.
A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical guidelines for the use of aspirin in preventative care.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tuyet Pham, MD 1402 W Avenue H, Temple, TX 76504-5342 Ph: (254) 771-8411 | Dr Tuyet Pham, MD 1402 W Avenue H, Temple, TX 76504-5342 Ph: (254) 771-8411 |
News Archive
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who received sorafenib or sunitinib after surgery (5.6 years) and those treated with placebo (5.7 years).
On Oct. 8, MicroMed Cardiovascular (www.micromedcv.com), manufacturer of the HeartAssist 5™ left ventricular assist device (LVAD), was selected as one of the Top 50 Emerging Companies in the nation's largest venture capital competition, the Sixth Annual Pitching Across America competition.
The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival.
A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical guidelines for the use of aspirin in preventative care.
› Verified 5 days ago
Dr. Matthew J. Furman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1905 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-298-2682 Fax: 254-778-7197 | |
Aishwaryakunverba Rathod, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2401 S 31st St # Ms -m2663, Temple, TX 76508 Phone: 254-771-8411 | |
Dr. Duren Michael Ready, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 Fax: 254-724-7603 | |
Dr. Darren E. Hamm, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1027 Fredrick Ln, Temple, TX 76502 Phone: 254-931-6665 | |
Tove Goldson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1402 W Avenue H, Temple, TX 76504 Phone: 254-771-8411 | |
Robert R Liu, MD, MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1901 Veterans Memorial Dr, C&p, Temple, TX 76504 Phone: 254-743-0430 | |
Hou Sheng Wu, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1901 S 1st St, Temple, TX 76504 Phone: 254-778-4811 Fax: 254-743-1134 |